22 Stocks Moving In Tuesday's Pre-Market Session

Loading...
Loading...


Gainers

  • Health Insurance Innovations Inc HIIQ rose 40.3 percent to $5.61 in pre-market trading after the company posted upbeat quarterly results and raised its FY16 guidance.
  • Endo International plc ENDP shares rose 12 percent to $20.38 in pre-market trading as the company announced stronger-than-expected results for the second quarter.
  • Castlight Health Inc CSLT rose 9.4 percent to $3.71 in pre-market trading. Castlight Health reported a Q2 loss of $0.17 per share on revenue of $23.58 million.
  • Nevro Corp NVRO shares rose 8.1 percent to $87.50 in pre-market trading after the company reported better-than-expected Q2 results and updated its FY 16 guidance.
  • Kandi Technologies Group Inc KNDI shares rose 7.1 percent to $8.30 in pre-market trading. Kandi Technologies reported Q2 earnings of $0.06 per share on revenue of $55.2 million.
  • AMAG Pharmaceuticals, Inc. AMAG rose 5.4 percent to $27.74 in pre-market trading as the company announced better-than-expected earnings for the latest quarter.
  • Opko Health Inc. OPK rose 4.2 percent to $10.53 in the pre-market trading session. OPKO Health reported quarterly earnings of $0.02 per share on revenue of $357 million.
  • Eagle Pharmaceuticals Inc EGRX shares rose 3.9 percent to $50.25 in pre-market trading. Eagle Pharma posted Q2 earnings of $0.84 per share on revenue of $40.9 million and reported positive outcome from the FDA meeting for Ryanodex for exertional heat stroke NDA submission.
  • Zeltiq Aesthetics Inc ZLTQ rose 3.3 percent to $35.00 in pre-market trading. ZELTIQ reported a Q2 loss of $0.12 per share on revenue of $89.46 million.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

  • TubeMogul Inc TUBE shares fell 22.9 percent to $9.75 in pre-market trading after the company reported a wider-than-expected quarterly loss.
  • Array Biopharma Inc ARRY shares declined 10.1 percent to $4.00 in the pre-market trading session. AstraZeneca reported that its Phase III trial of selumetinib in non-small cell lung cancer did not meet primary endpoint. Array BioPharma was informed of these results on Monday, August 8, 2016.
  • Manitowoc Company Inc MTW shares fell 9.3 percent to $5.25 in pre-market trading after the company posted downbeat quarterly revenue.
  • IAMGOLD Corp (USA) IAG shares fell 8.5 percent to $5.20 in pre-market trading as the company reported a bought deal financing of up to $230 million.
  • Norwegian Cruise Line Holdings Ltd NCLH dropped 8.2 percent to $39.44 in pre-market trading. Norwegian Cruise Line posted downbeat quarterly revenue and issued a weak earnings forecast.
  • Fox Factory Holding Corp FOXF fell 8.1 percent to $18.50 in pre-market trading. Fox Factory reported a secondary public offering of 3.5 million shares.
  • NeoPhotonics Corp NPTN shares dropped 7.8 percent to $12.35 in pre-market trading as the company posted downbeat Q2 revenue and issued a weak forecast for the current quarter.
  • VTTI Energy Partners LP VTTI fell 7 percent to $19.26 in pre-market trading. VTTI Energy priced a 5.25 million share offering at $19.30 per share. VTTI Energy reported a Q2 a loss of $3.4 million.
  • Gap Inc GPS shares fell 4.5 percent to $24.48 in pre-market trading. Gap reported a 4 percent drop in its July same-store sales. The company projects Q2 adjusted earnings of $0.58 to $0.59 per share.
  • United States Steel Corporation X shares fell 3.8 percent to $24.85 in pre-market trading. United States Steel reported a proposed common stock offering of 17 million shares.
  • B&G Foods, Inc. BGS fell 3.8 percent to $49.15 in pre-market trading. B&G Foods announced a public offering of 3.75 million shares of common stock.
  • BioMarin Pharmaceutical Inc. BMRN shares fell 3.6 percent to $95.49 in pre-market trading. BioMarin reported a public offering of 7.5 million shares of common stock.
  • ACADIA Pharmaceuticals Inc. ACAD shares fell 3.2 percent to $34.10 in pre-market trading. ACADIA Pharmaceuticals reported a proposed public offering of common stock of $200 million.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsMovers#PreMarket GainersLosersTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...